Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A 6-Week Safety & Efficacy Study of Combination Intraocular Pressure-Lowering Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
This study has been completed.
Sponsored by: Alcon Research
Information provided by: Alcon Research
ClinicalTrials.gov Identifier: NCT00051194
  Purpose

To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.


Condition Intervention Phase
Glaucoma, Open-Angle
Ocular Hypertension
Drug: Combination IOP Lowering Therapy
Phase II

Genetics Home Reference related topics: early-onset glaucoma
MedlinePlus related topics: Glaucoma High Blood Pressure
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A 6-Week Safety and Efficacy Study of Combination IOP-Lowering Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Adult patients of any race and either sex with open angle glaucoma or ocular hypertension.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00051194

Locations
United States, Texas
Europe
Fort Worth, Texas, United States
Sponsors and Collaborators
Alcon Research
Investigators
Principal Investigator: Alcon Investigators Alcon Research
  More Information

Study ID Numbers: C-02-03
Study First Received: January 3, 2003
Last Updated: March 3, 2006
ClinicalTrials.gov Identifier: NCT00051194  
Health Authority: United States: Food and Drug Administration

Keywords provided by Alcon Research:
Glaucoma
POAG
OAG
OHT

Study placed in the following topic categories:
Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 15, 2009